Active Ingredient: SELUMETINIB SULFATE
Proprietary Name: KOSELUGO
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 25MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N213756
Product Number: 002
Approval Date: Apr 10, 2020
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:
Prescription
Patent and Exclusivity Information
